Evidence map›Paper›PMID 30223797›Full record

ArticleBMC medical imaging2018

Standardized quality metric system for structural brain magnetic resonance images in multi-center neuroimaging study.

Michael E Osadebey, Marius Pedersen, Douglas L Arnold, Katrina E Wendel-Mitoraj, For The Alzheimer's Disease Neuroimaging Initiative

Abstract read
In one paragraph

Article in BMC medical imaging, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. DSMRI: Domain Shift Analyzer for Multi-Center MRI Datasets.Diagnostics (Basel, Switzerland) · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Michael E OsadebeyNeuroRx Research Inc, Montreal, 3575 Parc Avenue, Suite # 5322, Montreal, Quebec, H2X 3P9, Canada.
Marius PedersenDepartment of Computer Science, Norwegian University of Science and Technology, Teknologivegen 22, Gjøvik, N-2815, Norway. marius.pedersen@ntnu.no.ORCID 0000-0001-9797-5821
Douglas L ArnoldMontreal Neurological Institute and Hospital, McGill University, 3801 University St, Montreal, Quebec, H3A 2B4, Canada.
Katrina E Wendel-MitorajBrainCare Oy, Finn-Medi 1 PL 2000, Tampere, 33521, Finland.
For The Alzheimer's Disease Neuroimaging InitiativeThe Alzheimer's Disease Neuroimaging Initiative, Center for Imaging of Neurodegenerative Disease, San Francisco VA Medical Center, University of California, San Francisco, USA.

Funding

Alzheimer's Disease Neuroimaging Initiative - SupplementU01AG024904 · NIA · NORTHERN CALIFORNIA INSTITUTE RES &EDUC · PI WEINER, MICHAEL W · 2004 to 2015
$121.0M
CIHRNIA NIH HHS U01 AG024904
6 · The paper itself

Abstract

backgroundMulti-site neuroimaging offer several benefits and poses tough challenges in the drug development process. Although MRI protocol and clinical guidelines developed to address these challenges recommend the use of good quality images, reliable assessment of image quality is hampered by the several shortcomings of existing techniques.

methodsGiven a test image two feature images are extracted. They are grayscale and contrast feature images. Four binary images are generated by setting four different global thresholds on the feature images. Image quality is predicted by measuring the structural similarity between appropriate pairs of binary images. The lower and upper limits of the quality index are 0 and 1. Quality prediction is based on four quality attributes; luminance contrast, texture, texture contrast and lightness.

resultsPerformance evaluation on test data from three multi-site clinical trials show good objective quality evaluation across MRI sequences, levels of distortion and quality attributes. Correlation with subjective evaluation by human observers is ≥ 0.6.

conclusionThe results are promising for the evaluation of MRI protocols, specifically the standardization of quality index, designed to overcome the challenges encountered in multi-site clinical trials.

Indexed as

AlgorithmsBrainClinical Trials as TopicHumansMagnetic Resonance ImagingMetric SystemMulticenter Studies as TopicNeuroimagingRadiographic Image EnhancementBrain MRIGrayscale feature imageImage momentImage qualityLocal contrast feature imageMagnetic resonance imaging (MRI)

Identifiers

PMID30223797
PMCPMC6142697

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.